Ventria Bioscience is embarking on a path of accelerated growth as they work to double their capacity for multiple products this year. As part of… Continue Reading →
The Chase Group, committed to executive recruitment in life sciences, is pleased to announce the completion of another search for Alexza Pharmaceuticals, successfully securing Mike… Continue Reading →
Alexza Pharmaceuticals stands at the crossroads of innovation and advanced technology with a platform that has the potential to address unmet medical needs in neuroscience…. Continue Reading →
The Chase Group (TCG) is pleased to announce the successful recruitment of David Geller, MD as the Vice President, Pulmonary and Rare Diseases Clinical Development… Continue Reading →
Ionis Pharmaceuticals retained The Chase Group to identify and secure the next member of their drug safety leadership team to support a robust and continually… Continue Reading →
The combination of expertise and passion to build transformative, life-changing medicines for patients and their families positions Arcturus Therapeutics to catalyze the next generation of… Continue Reading →
The Chase Group, known for relationship building with proven success in life sciences executive search, was retained by Akcea Therapeutics, to identify and secure a… Continue Reading →
After a comprehensive executive search that was filled in less than two months, The Chase Group is pleased to announce the placement of Carla Poulson… Continue Reading →
Akcea Therapeutics is driven by determination and focus on addressing the unmet needs and complex medical challenges of patients with serious and rare disorders. As… Continue Reading →
Eisai, Inc.’s partnership with Merck has proven to be successful with the FDA approval of the Keytruda and Lenvima Combination Treatment. With 13 indications for… Continue Reading →